{"id":"tp-50831","type":"article-newspaper","title":"Starling Oncology, Inc. Revenue Beats Estimates by $1.11 Million in Q3","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50831","datePublished":"2026-11-07T13:02:33.000Z","dateModified":"2026-11-07T13:02:33.000Z","language":"en","abstract":"The company posted a 14-cent GAAP loss per share and positive adjusted EBITDA of $3.4 million. Cash and cash equivalents totaled $36.9 million as of Sept. 30.","section":"Business","references":[]}